INT160135

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.43
First Reported 2009
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.05
Pain Relevance 0.27

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

small molecule metabolic process (CYP2C9) oxidoreductase activity (CYP2C9) endoplasmic reticulum (CYP2C9)
Anatomy Link Frequency
liver 2
CYP2C9 (Homo sapiens)
Pain Link Frequency Relevance Heat
fluoxetine 1 94.96 High High
Gabapentin 3 72.44 Quite High
anticonvulsant 2 72.08 Quite High
carbamazepine 12 71.56 Quite High
Lamotrigine 5 53.68 Quite High
antiepileptic Drug 19 31.88 Quite Low
sodium channel 11 5.00 Very Low Very Low Very Low
headache 5 5.00 Very Low Very Low Very Low
Neuropathic pain 1 5.00 Very Low Very Low Very Low
amygdala 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Convulsion 35 50.52 Quite High
Epilepsy 24 50.00 Quite Low
Body Weight 2 13.28 Low Low
Partial Seizures 14 5.00 Very Low Very Low Very Low
Vomiting 7 5.00 Very Low Very Low Very Low
Dizziness 5 5.00 Very Low Very Low Very Low
Headache 5 5.00 Very Low Very Low Very Low
Cognitive Disorder 4 5.00 Very Low Very Low Very Low
Diplopia 4 5.00 Very Low Very Low Very Low
Depression 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
By a series of docking studies and MD simulations, the binding pockets of CYP2C9 for the five drugs are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into the metabolic mechanism, which may be of relevance to the personalized drug.
Negative_regulation (defined) of CYP2C9 Binding (binding) of
1) Confidence 0.43 Published 2009 Journal Medicinal chemistry (Sh?riqah (United Arab Emirates)) Section Abstract Doc Link 19442216 Disease Relevance 0 Pain Relevance 0.09
The activity of CYP1A2, CYP2A6, CYP2B6, CYP2D6, CYP2E1, CYP3A4, and CYP2C9 was not affected, and only a moderate inhibitory effect on CYP2C19 (by 38%), as well as a moderate increment of UDP-glucuronosyl-transferase 1A1-mediated ethinylestradiol glucuronidation (by 39%), was seen in the presence of ESL in human liver microsomes in vitro.36

In vivo studies

Neg (not) Negative_regulation (affected) of CYP2C9 Binding (activity) of in liver
2) Confidence 0.18 Published 2010 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2987506 Disease Relevance 0.05 Pain Relevance 0.17

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox